Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lantmännen Biorefineries is a prominent Swedish industrial biotechnology company and a core division of the Lantmännen agricultural cooperative. The company operates advanced biorefineries that process grain—primarily wheat and oats—into high-quality ingredients such as proteins, starches, gluten, and sustainable ethanol. Its specialized health-related portfolio includes PromOat (oat beta-glucan), which is clinically recognized for cholesterol management, and high-purity oat oil for dermatological applications. By employing a circular production model, the company converts agricultural raw materials into bio-based alternatives for the food, feed, pharmaceutical, and energy industries. Lantmännen Biorefineries is a key player in the European bioeconomy, focusing on sustainability and the upcycling of domestic crops.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lantmännen Biorefineries.